ESR1 and neoplasm: Further problems in generalizing this approach include confident selection of a truncal mutation and understanding the functional significance of sub clones, as seen here with the contrasts between PIK3CA and ESR1. Technically the best method for measuring the tumor content of plasma for early changes remains uncertain.